Hantzsch Synthesis of 2,6-Dimethyl-3,5-dimethoxycarbonyl-4-(o-methoxyphenyl)-1,4-dihydropyridine; a Novel Cyclisation Leading to an Unusual Formation of 1-Amino-2-methoxycarbonyl-3,5-bis(o-methoxyphenyl)-4-oxa-cyclohexan-1-ene by Filipan-Litvić, Mirela et al.
Molecules 2007, 12, 2546-2558 
molecules 
ISSN 1420-3049 
© 2007 by MDPI 
www.mdpi.org/molecules 
Full Paper 
 
Hantzsch Synthesis of 2,6-Dimethyl-3,5-dimethoxycarbonyl-4-
(o-methoxyphenyl)-1,4-dihydropyridine; a Novel Cyclisation 
Leading to an Unusual Formation of 1-Amino-2-methoxy-
carbonyl-3,5-bis(o-methoxyphenyl)-4-oxa-cyclohexan-1-ene 
 
Mirela Filipan-Litvić 1, Mladen Litvić 1,*, Ivica Cepanec 1 and Vladimir Vinković 2 
 
1 BELUPO Pharmaceuticals, Inc. R&D, Danica 5, 48000 Koprivnica, Croatia;  
E-mail: mirela.filipan-litvic@belupo.hr; E-mail: ivica.cepanec@belupo.hr 
2 Institute Ruđer Bošković, Bijenička c. 54, 10002 Zagreb, Croatia; E-mail: vvink@irb.hr 
 
* Author to whom correspondence should be addressed. E-mail: mladen.litvic@belupo.hr; Tel: (+385) 
48 652 458; Fax: (+385) 48 652 461. 
 
Received: 9 November 2007; in revised form: 22 November 2007 / Accepted: 23 November 2007 / 
Published: 26 November 2007 
 
 
Abstract: Hantzsch condensation of two equivalents of methyl-3-aminocrotonate with (m- 
and p)-methoxybenzaldehyde afforded the expected products 2,6-dimethyl-3,5-
dimethoxycarbonyl-4-(m-methoxyphenyl)-1,4-dihydropyridine and 2,6-dimethyl-3,5-
dimethoxycarbonyl-4-(p-methoxyphenyl)-1,4-dihydropyridine, whereas o-methoxy-
benzaldehyde produced mainly 1-amino-2-methoxycarbonyl-3,5-bis(o-methoxy-phenyl)-4-
oxa-cyclohexan-1-ene. The structure of the product, not previously reported in the 
literature, was determined by 1D and 2D NMR spectra and its MS fragmentation. This is 
the first example of cyclisation leading to a substituted pyran rather than 1,4-DHP under 
typical Hantzsch reaction conditions. A plausible mechanism for its formation is 
postulated. 
 
Keywords: Hantzsch condensation, intramolecular Michael addition, deprotonation, 
substituted pyrane. 
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Introduction 
 
The first synthesis of a 1,4-dihydropyridines (1,4-DHPs) via a three component cyclocondensation 
reaction of acetoacetic ester, aldehyde and ammonia was reported by Arthur Hantzsch in 1882 [1]. 
Since then a lot of new variants of original method have been developed, allowing synthesis of 
different substituted 1,4-DHPs (Scheme 1) [2].  
1,4-DHPs have now been recognised as vital drugs in treatment of angina and hypertension. Some 
of the representatives (nifedipine [3], felodipine [4], nicardipine [5] and amlodipine [6], Figure 1) have 
been commercialised and it has been proven that their pharmaceutical action is related to binding to 
voltage dependent L-type of calcium channel and thus decreasing the passage of calcium ions to the 
cell. The result is relaxation of smooth muscle cells and lowering the blood pressure. Recently, the 
other mechanism on molecular level have been found and is based on increasing NO release from the 
intact endothelium [7]. As a result, newly synthesized generations of 1,4-DHPs possess different 
pharmacological activities such as: anticancer [8], bronchodilating [9], antidiabetic [10], neurotropic 
[11], antianginal [12] and other pharmacological activities [13]. 
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As it can be seen from the Scheme 1, methods A and C are only convenient for the synthesis of 
symmetrical, nonchiral 1,4-DHPs (R=R') [14-16], while methods B (two step synthesis via 
Knoevenagel intermediate IV) and D (three component cyclocondensation) are usually used for the 
synthesis of 1,4-DHPs having different ester moieties (R≠R’) [17-20]. 
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Scheme 1. Most common variants of the Hantzsch 1,4-DHP synthesis. 
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As one might predict, symmetrical 1,4-DHPs are always formed as impurities in synthesis of 
nonsymmetrical 1,4-DHPs. However, formation of impurities other than intermediates leading to the 
1,4-DHP ring is rarely described in Hantzsch condensations [21]. Thus, Angeles et. al. [22] have 
isolated four different compounds 1-4 (Figure 2) from the Hantzsch condensation of 2-nitro-
benzaldehyde, NH4OH and acetoacetic acid ethyl ester. The formation of 1,2-dihydropyridine 2, cyclic 
amide 3 and substituted hydroxamic acid 4 is possibly due to steric hindrance as well as the oxidative 
ability of the nitro group in the ortho- position. Similar observations have not yet been published for 
other substituents (OCH3, Cl, CH3 etc.). 
 
Figure 2. 
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Görlitzer et. al. [23] have studied the dimerisation of o-nitrobenzylideneacetic acid esters and 
isolated two diastereomeric substituted hexenes which could also be present as impurities in the 
classical Hantzsch condensation. 
As part of a continuing effort in our laboratory toward the development of new methods for the 
synthesis and aromatization of 1,4-DHPs [24], we required gram scale samples of some substituded 
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1,4-DHPs having a OCH3 group in the ortho-, meta- and para- position on the aromatic ring. Taking 
into account a wide variety of methods for 1,4-DHP synthesis, as well as our previous experience in 
Hantzsch 1,4-DHP synthesis [25], we decided to use method C (Scheme 1) as most convenient for 
synthesis when employing sterically demanded ortho-substituted benzaldehydes as starting material. 
 
Results and Discussion 
 
The Hantzsch condensation of all three (o-, m- and p)-methoxybenzaldehyde isomers 5-7 with two 
equivalents of methyl-3-aminocrotonate (8) was carried out at reflux temperature in isopropanol as 
solvent (Scheme 2). According to our previous experience with the chemistry of 1,4-DHPs the latter 
solvent was proven to be better than other alcohols (such as ethanol, methanol, etc.) due to the easier 
crystallisation of the product from the cold reaction mixture. With respect to other methods, method C 
(Scheme 1) has been rarely mentioned in the modern literature as the method of choice for synthesis of 
simple 1,4-DHPs although it has some advantages over the other methods such as the amount of water 
formed in the reaction (one mol compared to three moles in method A), which is a key factor in 
Hantzsch 1,4-DHP syntheses employing sterically demanding benzaldehydes [25]. The reactions were 
monitored by TLC (9:1 CH2Cl2/AcOEt as eluent) until the disappearance of the starting benzaldehydes 
and methyl-3-aminocrotonate (8). In the cases of the (m- and p)-methoxybenzaldehydes 6, 7 the 
reactions were completed after 23 and 17 h respectively (Table 1). As expected the reaction with the 
sterically demanding o-methoxybenzaldehyde (5) was much slower and was complete after 84 h. To 
our surprise, a quite intensive methyl-3-aminocrotonate (8) spot of was still present at the end of 
reaction but not traces of 5 were noted. 
Scheme 2. 
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The all reaction mixtures were cooled to room temperature to obtain crystalline products which 
were collected by filtration. The products thus obtained were analysed by TLC, IR, MS and NMR (1H 
and 13C) spectroscopy to determine their structures. The corresponding m- and p-methoxy derivatives 
10 and 11 were prepared in 28.8 % and 15.3 % yields, respectively. 
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Table 1. The results of Hantzsch condensation of (o-, m- and p)-methoxybenzaldehydes 
5-7 with methyl-3-aminocrotonate (8). 
Entry R Product 
Reaction 
time[h]a 
Yields after 
crystallisation [%] 
mp Rf (TLC) 
1 o-MeOC6H4 9 84 25.6 170.0 - 171.5 0.11b 
2 m-MeOC6H4 10 23 28.8 168.0 - 170.5 0.39c 
3 p-MeOC6H4 11 17 15.3 172.5 - 175.0 0.47c 
a Determined by TLC; b CH2Cl2/MeOH, 9:1 as eluent; c CH2Cl2/AcOEt, 9:1 as eluent. 
 
Although the majority of the products were soluble in the mother liquors, the purities of crystals 
were very high (>98 %), which was sufficient for further testing. To our surprise the product 9 
obtained with o-methoxybenzaldehyde (5) had much higher polarity (Table 1) than was expected [Rf 
(CH2Cl2/MeOH, 9:1) = 0.11], compared to similar 1,4-DHP derivatives [Rf (CH2Cl2/MeOH, 9:1) > 
0.90], which suggested formation of a product of different structure than 1,4-DHP. By careful 
assignment of the 1H- and 13C-NMR spectra the structure 9 was elucidated. The 1H-NMR spectrum 
(aromatic region) showed incorporation of two molecues of o-methoxybenzaldehyde (5) and one 
molecule of methyl-3-aminocrotonate (8). An interesting observation was made in the aliphatic region 
for CDCl3 and DMSO-d6 solutions. Two diastereotopic protons (at position 5) are clearly seen only in 
DMSO-d6 solution, suggesting a rigid structure 9B (Figure 3) with an intramolecular hydrogen bond. 
Additional proof are the two different shifts of the NH protons. Contrary to 9B, the flexible structure 
9A is present in CDCl3 solution, where the NH2 group gives a broad signal at 2.2 ppm and the 
diastereotopic protons appear as one signal at 2.5 ppm. To our surprise, from NOESY spectra it was 
clearly proved that the two aromatic rings occupy the syn- position. However, it cannot be claimed that 
only the syn-conformer is exclusively formed in the reaction. Rather, it is more likely that the anti-
conformer is more soluble in the reaction mixture in comparison to the syn- one and hence the 
crystalline product is exclusively the syn-conformer. 
 
Figure 3. 
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According to MS spectra the high intensity of the molecular ion (m/z = 369, 79 %) indicates the 
stability of structure 9. Plausible fragmentation pathways, which are consistent with the spectral data, 
together with the structures which are suggested for fragment ions, are shown in Scheme 3.  
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After formation of the molecular ion, fragment ion 13 (m/z 234, 100 %) is formed by unexpected 
elimination of o-methoxybenzaldimine (12). This process starts with intramolecular addition of the 
amino group to the more reactive benzylic position in the molecule, followed by elimination of 12. 
Further fragmentation involves the elimination of one molecule of methyl-2-butynoate (14) and the 
formation of 16, a radical cation of o-methoxybenzaldehyde (16) at m/z 136 (19 %). The second 
pathway involves one step elimination of a substituted cyclobutane molecule 15 to form the radical 
cation 16. 
Scheme 3. 
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Additional proof for the structure 9 was obtained by performing the reaction with two equivalents 
of o-methoxybenzaldehyde (5) and one equivalent of freshly prepared methyl-3-aminocrotonate (8), 
(Scheme 4).  
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The latter compound was prepared by the method developed in our laboratory, via the reaction of 
methyl acetoacetate (17) and ammonium carbamate in methanol at room temperature [26]. The crude 8 
of high purity (>99%) was then subjected to reaction with 5 for the same time as original reaction (84 
h). After crystallisation from reaction mixture the product 9 was obtained in good yield (51 %). These 
findings clearly indicate that two molecules of o-methoxybenzaldehyde (5) were incorporated in the 
molecule. Additionally, the purity of methyl-3-aminocrotonate (8) also plays an important role in the 
overall yield of the product. 
As mentioned above, o-methoxy-substituted-1,4-DHP 18 is proven to be formed in the reaction 
according to Scheme 2, but only as a mixture with unreacted methyl-3-aminocrotonate (8) and other 
impurities (by TLC analysis). A chromatographic separation, due to the small differences in the Rf 
values, was not convenient for its isolation from the mother liquor and therefore we decided to 
synthesize it employing different Hantzsch conditions (Scheme 5).  
 
Scheme 5. 
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Thus, two equivalents of methyl acetoacetate (12), ammonium acetate and 2-methoxybenzaldehyde 
(5) were subjected to reaction in refluxing isopropanol during 22 h to give the expected 1,4-DHP 18 in 
37.8 % yield after crystalization from methanol. It is interested to note that even a trace of impurity 9 
was observed in this reaction. It seems that its formation is characteristic only for Hantzsch method C, 
Scheme 1. To prove this hypothesis we look at the mechanism of its formation according to reaction 
condition in Scheme 2. The plausible mechanism is presented in Scheme 6. 
The mechanism involves initial nucleophilic attack on o-methoxybenzaldehyde (5) by methyl-3-
aminocrotonate (8) to form the ionic intermediate 19, which upon proton tranfer gives the 
iminoalcohol 20. In the next step dehydration leads to formation of the imino-Knoevenagel 
intermediate 21. These types of compounds have been described by Kim et. al. [27] as metastable 
intermediates in the aza-Diels-Alder condensation, a key step in the synthesis of the antyhypertensive 
drug amlodipine. As one could predict, the next step would be Michael addition of a second molecule 
of methyl-3-amino-crotonate (8) to 5, according to the proven and accepted mechanism for the 
Hantzsch condensation [28]. However, due to steric hindrance by the influence of methoxy group in 
the ortho- position, as well as its electron donating ability, the carbon-carbon double bond is poorly 
reactive towards Michael addition. Similarly, anthracene-9-carbaldehyde is easily converted to 
Knoevenagel intermediate 25 employing Hantzsch reaction conditions, but at this stage the reaction is 
stopped although sufficient amounts of acetoacetate ester and ammonia are present in the reaction 
medium [29]. For this reason, 9-anthryl-1,4-DHPs have not been prepared so far in Hantzsch 
condensations. 
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Scheme 6. 
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According to TLC analysis of the reaction mixture the formation of 1,4-dihydropyridine 18 is also 
observed, suggesting that intermediate 21 (Figure 4) is not as completely unreactive as the 9-anthryl-
analogue 25. However, the presence of higly basic ammonia in the reaction mixture (refluxing i-PrOH) 
causes deprotonation of the methyl group rather than Michael addition of the second molecule of 
methyl-3-aminocrotonate (8). Thus formed carbanion 21, in which the negative charge is delocalised 
and stabilised by interacting with the double bonds and electronegative nitrogen and oxygen atoms in 
the molecule is highly nucleophillic and reacts with a second molecule of o-methoxybenzaldehyde (5) 
to yield intermediate 23, which upon fast intramolecular Michael addition and protonation gives the 
final product 9. 
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In summary, the main reasons that determined formation of 9 rather than the expected 1,4-DHP 18 
are: a) the steric hindrance and electron donating ability of the o-methoxy group; b) the presence of 
basic ammonia formed in reaction; c) the slow bimolecular Michael addition of methyl-3-amino-
crotonate (8) to the imino-Knoevenagel intermediate 21. 
 
Conclusions 
 
We believe that this type of side product formation is characteristic of Hantzsch condensations 
employing two equivalents of alkyl-3-aminocrotonates and substituted benzaldehydes, but the amounts 
formed may vary drastically, depending on the nature of the substituents present on the aromatic ring. 
The preliminary experiments with benzaldehydes having Cl, CH3, and OEt on the ortho- position have 
shown formation of traces of impurities with similar polarities as 9 (TLC), but the amounts were not 
sufficient for their isolation by crystallisation. Further attempts to isolate analytical samples for 
structure determination are now in progress and the results will be published elsewhere in due course. 
 
Experimental 
 
General 
 
IR Spectra were recorded on a Perkin-Elmer 297 instrument. 1H- and 13C-NMR spectra were 
recorded using a Bruker 600 spectrometer in the solvents indicated (referenced to the residual 1H 
signals in the deuterated solvents) using TMS as internal standard. Chemical shifts are reported in ppm 
(δ scale), coupling constant (J) values are given in Hertz (Hz). Electron impact (EI) mass spectra were 
recorded using a LC-MS (2795, Waters Micromass Q-ToF) instrument operated at 3.0 kV ionization 
energy. Elemental analyses were done by the Central Analytical Service (CAS) at the Ruđer Bošković 
Institute, Zagreb. Melting points were measured on a Büchi Melting Point B 540 apparatus and are 
uncorrected. Thin layer chromatography (TLC) analyses were performed on Merck aluminium plates 
coated with silica gel (60 F254). Compounds were visualised by ultra-violet irradiation at 254 and 366 
nm. 
 
General procedure for the Hantzsch condensation 
 
To a solution of corresponding substituted benzaldehyde 5-7 (0.2 mol) in i-PrOH (50 mL) methyl-
3-aminocrotonate (8, 46.05 g, 0.4 mol) was added at once. The reaction mixture was heated at reflux 
temperature for the time indicated in Table 1, and then cooled to rt. The obtained crystals of products 
9-11 were filtered, washed with i-PrOH (3 x 20 mL) and dried in vacuum to constant weight. 
 
1-Amino-2-methoxycarbonyl-3,5-bis(o-methoxyphenyl)-4-oxa-cyclohexan-1-ene (9). Pale yellow 
crystals; yield: 9.47 g (25.6 %); Rf (CH2Cl2/MeOH, 9:1)=0.11; mp 170.0–171.5 °C; IR (KBr): ν=3530, 
3399, 3298, 3214, 3075, 2959, 2944, 1658, 1622, 1602, 1585, 1542, 1488, 1459, 1441, 1417, 1364, 
1341, 1310, 1293, 1263, 1242, 1186, 1162, 1124, 1099, 1071, 1053, 1026, 999, 968, 947, 929, 888, 
862, 844, 812, 795, 783, 757, 641, 596, 572, 528 cm-1; 1H-NMR (CDCl3): δ=2.20 (br., s, 2H, NH2), 
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2.50 (d, 2H, CH2, J=6.8 Hz), 3.50 (s, 3H, OCH3), 3.59 (s, 3H, OCH3), 3.84 (s, 3H, COOCH3), 4.10 (t, 
1H, CH, J=7.5 Hz), 5.50 (s, 1H, CH), 6.76 (d, 1H, arom., J=8.2 Hz), 6.85–6.92 (m, 2H, arom.), 6.96 
(d, 1H, arom., J=7.4 Hz), 7.16–7.24 (m, 3H, arom.), 7.46 (dd, 1H, arom., J1=7.5, J2=1.5); 13C-NMR 
(CDCl3): δ=36.42, 44.44, 50.53, 50.56, 55.13, 55.31, 91.89, 110.07, 110.24, 110.64, 119.48, 120.88, 
125.93, 127.61, 128.01, 128.83, 131.78, 132.57, 156.70, 157.16, 157.64, 169.47; MS (3.0 kV, EI,): m/z 
(%) for C21H23NO5: 369 (79), 234 (100), 136 (19); anal. calcd. for C21H23NO5: C 68.28, H 6.28, N 
3.79, O 21.66; found: C 68.37, H 6.39, N 3.61. 
 
2,6-Dimethyl-3,5-dimethoxycarbonyl–4-(m-methoxyphenyl)-1,4-dihydropyridine (10). Yellow crystals; 
yield: 19.06 g (25.6 %); Rf (CH2Cl2/AcOEt, 9:1)=0.39; mp 168.0–170.5 °C; IR (KBr): ν=3348, 3241, 
3091, 3029, 3004, 2953, 2837, 1704, 1651, 1626, 1606, 1580, 1486, 1449, 1434, 1380, 1346, 1317, 
1296, 1263, 1219, 1181, 1157, 1134, 1120, 1099, 1047, 1016, 964, 949, 895, 871, 810, 775, 752, 735, 
716, 682, 637, 584, 563 cm-1; 1H-NMR (CDCl3): δ=2.28 (s, 6H, CH3), 3.65 (s, 6H, COOCH3), 3.75 (s, 
3H, OCH3), 5.00 (s, 1H, CH), 6.23 (s, 1H, NH), 6.68 (dd, 1H, arom., J1 = 8.1 Hz; J2 = 1.9 Hz), 6.82–
6.88 (m, 2H, arom.), 7.13 (t, 1H, arom., J = 7.9 Hz); 13C-NMR (CDCl3): δ=19.12, 38.98, 50.80, 54.84, 
103.18, 110.65, 113.72, 119.91, 128.73, 144.54, 148.85, 159.13, 167.98; Anal. calcd. for C18H21NO5: 
C 65.24, H 6.39, N 4.23, O 24.14; found: C 65.1, H 6.5, N 4.3. 
 
2,6-Dimethyl-3,5-dimethoxycarbonyl–4-(p-methoxyphenyl)-1,4-dihydropyridine (11). Pale yellow 
crystals; yield: 10.10 g (15.3 %); Rf (CH2Cl2/AcOEt, 9:1)=0.47; mp 172.5–175.0 °C; IR (KBr): 
ν=3365, 3096, 3001, 2950, 2838, 1680, 1653, 1613, 1512, 1486, 1431, 1377, 1336, 1302, 1256, 1229, 
1174, 1147, 1128, 1093, 1049, 942, 843, 817, 805, 787, 745, 665, 631, 604, 587, 546, 525 cm-1; 1H- 
NMR (CDCl3): δ=2.33 (s, 6H, CH3), 3.65 (s, 6H, COOCH3), 3.75 (s, 3H, OCH3), 4.94 (s, 1H, CH), 
5.67 (s, 1H, NH), 6.75 (d, 2H, arom.; J=8.5 Hz), 7.18 (d, 2H, arom., J=8.5 Hz); 13C-NMR (CDCl3): 
δ=19.29, 38.24, 50.80, 54.95, 103.78, 113.21, 128.40, 139.81, 143.97, 157.76, 168.01; Anal. calcd. for 
C18H21NO5: C 65.24, H 6.39, N 4.23, O 24.14; found: C 65.3, H 6.2, N 4.2. 
 
Synthesis of 1-amino-2-methoxycarbonyl-3,5-bis(o-methoxyphenyl)-4-oxa-cyclohexan-1-ene (9). To a 
solution of methyl acetoacetate (12, 5.40 mL, 5.81 g, 50 mmol) in methanol (50 mL) ammonium 
carbamate (NH4OOCNH2, 3.90 g, 50 mmol) was added at once. The resulting suspension was stirred at 
room temperature untill all solid material was dissolved (about 15 min). After that the solvent was 
evaporated off to yield white crystals of crude 8 (yield quantitative) which was suspended in i-PrOH 
(40 mL). To the resultant suspension o-methoxybenzaldehyde (5, 12.08 mL, 13.62 g, 100 mmol) were 
added dropwise during 15 min and after that the reaction mixture was heated under reflux temperature 
for 84 h with stirring. After cooling to room temperature the suspesion was cooled in refrigerator (-
18°C) for 12 h. The obtained crystals were filtered, washed with cold i-PrOH (2 x 10 mL) and dried in 
vacuum to constant weight to give 9.42 g (51.0 %) of 9 as a yellow crystals. The analytical data were 
in accordance with the sample obtained according to Scheme 2. 
 
Synthesis of 2,6-dimethyl-3,5-dimethoxycarbonyl–4-(o-methoxyphenyl)-1,4-dihydropyridine (18). To a 
suspension of ammonium acetate (0.05 mol, 3.85 g) in i-PrOH (50 mL), methyl acetoacetate (17, 0.1 
mol; 11.61 g, 10.75 mL) and o-methoxybenzaldehyde (5, 0.05 mol, 6.81 g, 6.04 mL) were added 
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dropwise during 15 min. The resultant suspension was heated under reflux temperature for 22 h with 
stirring. After cooling to room temperature reaction mixture was filtered and evaporated to dryness. 
The residue was disolved in methanol (25 mL) and the resultant clear solution was cooled in 
refrigerator (-18°C) for 12 h. The obtained crystals were filtered, washed with cold methanol (2 x 5 
mL) and dried in vacuum to constant weight to give 6.27 g (37.8 %) of 18 as a yellow crystals, Rf 
(CH2Cl2/AcOEt, 9:1)=0.46; mp 129.0–131.5 °C; IR (KBr): ν= 3337, 3068, 2993, 2945, 2837, 1706, 
1683, 1651, 1584, 1489, 1464, 1433, 1381, 1353, 1335, 1310, 1288, 1212, 1143, 1128, 1096, 1051, 
1028, 942, 857, 837, 823, 799, 786, 760, 687, 640, 591 cm-1; 1H-NMR (CDCl3): δ=2.24 (s, 6H, CH3), 
3.61 (s, 6H, COOCH3), 3.78 (s, 3H, OCH3), 5.29 (s, 1H, CH), 6.28 (s, 1H, NH), 6.78–6.90 (m, 2H, 
arom.), 7.07–7.16 (m, 2H, arom.); 13C-NMR (CDCl3): δ=18.78, 34.60, 50.63m, 55.29, 102.40, 110.71, 
120.05, 127.09, 129.47, 134.98, 144.16, 156.69, 168.47; Anal. calcd. for C18H21NO5: C 65.24, H 6.39, 
N 4.23, O 24.14; found: C 65.4, H 6.1, N 4.1. 
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